Queen Máxima opens ADORE Research building with spotlight on Neurospector
Photography by Mark van den Brink, Amsterdam UMC
14 May 2025
On Wednesday, May 14, Queen Máxima of the Netherlands officially opened the ADORE Research and Diagnostics Centre in Amsterdam. This cutting-edge facility, an initiative of Amsterdam UMC, brings together Neuroscientists and Oncology researchers, making it the largest onco-neuro campus worldwide.
The ADORE Centre (Amsterdam Oncology and Neuroscience Research) is a pioneering facility, the first of its kind to establish a structural collaboration between cancer and neuroscience experts. By integrating the fields of neurology and oncology, ADORE fosters interdisciplinary partnerships and promotes the exchange of knowledge, accelerating the development of innovative healthcare solutions for a broad range of patients.
During the opening ceremony, senior researcher Ana Carreras Mascaro from the Neurospector team gave the Queen a glimpse of our cultured human neurons through a microscope, sharing insights from our work on drug development using patient-derived human neurons.
14 May 2025
On Wednesday, May 14, Queen Máxima of the Netherlands officially opened the ADORE Research and Diagnostics Centre in Amsterdam. This cutting-edge facility, an initiative of Amsterdam UMC, brings together Neuroscientists and Oncology researchers, making it the largest onco-neuro campus worldwide.
The ADORE Centre (Amsterdam Oncology and Neuroscience Research) is a pioneering facility, the first of its kind to establish a structural collaboration between cancer and neuroscience experts. By integrating the fields of neurology and oncology, ADORE fosters interdisciplinary partnerships and promotes the exchange of knowledge, accelerating the development of innovative healthcare solutions for a broad range of patients.
During the opening ceremony, senior researcher Ana Carreras Mascaro from the Neurospector team gave the Queen a glimpse of our cultured human neurons through a microscope, sharing insights from our work on drug development using patient-derived human neurons.